You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海利生物(603718.SH):子公司楊凌金海取得換髮獸藥產品批准文號批件
格隆匯 12-25 15:59

格隆匯 12 月 25日丨海利生物(603718.SH)公佈,公司控股子公司楊凌金海生物技術有限公司(“楊凌金海”)由於原獸藥產品批准文號批件於2020年11月30日到期,已於2020年12月21日取得中華人民共和國農業農村部換髮的“豬口蹄疫O型、A型二價滅活疫苗(OHM/02株+AKT-Ш株)”和“口蹄疫O型、A型二價滅活疫苗(OHM/02株+AKT-III株)(懸浮培養工藝)”的新獸藥產品批准文號批件。

豬口蹄疫O型、A型二價滅活疫苗(OHM/02株+AKT-Ш株):企業名稱:楊凌金海生物技術有限公司;獸藥產品批准文號:獸藥生字270487544;生產地址:陝西省楊淩示範區東環北路31號;通用名稱:豬口蹄疫O型、A型二價滅活疫苗(OHM/02株+AKT-Ш株);商品名稱:無;含量規格:20ml/瓶;50ml/瓶;100ml/瓶;有效期:2020-12-21至2025-12-20;監測期:2020-12-21至2022-02-10;發證日期:2020-12-21。

口蹄疫O型、A型二價滅活疫苗(OHM/02株+AKT-III株)(懸浮培養工藝):企業名稱:楊凌金海生物技術有限公司;獸藥產品批准文號:獸藥生字270487541;生產地址:陝西省楊淩示範區東環北路31號;通用名稱:口蹄疫O型、A型二價滅活疫苗(OHM/02株+AKT-III株)(懸浮培養工藝);商品名稱:無;含量規格:20ml/瓶;50ml/瓶;100ml/瓶;有效期:2020-12-21至2025-12-20;發證日期:2020-12-21。

此次獸藥產品批准文號批件換髮是基於原證到期的正常換髮,新證的及時取得確保了子公司產品的正常生產,有利於公司整體生產經營的持續和穩定。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account